ASTRO会议:低剂量放疗在早期膝骨关节炎中显示潜力
ASTRO: Low-dose radiotherapy shows potential in early knee osteoarthritis
一项在ASTRO年会上报告的综合分析显示,针对292名症状性Kellgren-Lawrence 0-2级膝骨关节炎患者的随机对照试验中,联合正电压低剂量放疗(4.5 Gy,10次分次)相比单独使用SYSADOA,在疼痛、身体功能和生活质量方面带来更大且更持久的改善,且MRI显示结构进展更少。
该分析提供了低剂量放疗在早期膝骨关节炎中延缓疾病进展并减少全膝置换率的随机对照证据,可供临床决策参考。
Low-dose radiotherapy (LDRT) offers multiple benefits in early knee osteoarthritis (OA), according to a study presented at the annual meeting of the American Society for Radiation Oncology, held from Sept. 26 to 30 in Boston.
Maria Makarova, M.D., Ph.D., from Northern State Medical University in Arkhangelsk, Russia, and colleagues presented an integrated analysis of a completed randomized trial to examine the effect of LDRT in early knee OA. A total of 292 patients with symptomatic Kellgren–Lawrence (KL) grade 0 to 2 knee OA were randomly assigned to symptomatic slow-acting drugs for OA (SYSADOA) alone or SYSADOA plus orthovoltage LDRT (4.5 Gy in 10 fractions; 146 individuals in each group).
The researchers observed greater and more durable improvements in pain, physical function and quality of life with LDRT than with SYSADOA alone. Significantly less structural progression was demonstrated on magnetic resonance imaging, including a reduction in the overall Whole-Organ Magnetic Resonance Imaging Score at 12 and 36 months; there was also less cartilage deterioration and bone marrow edema progression.
LDRT reduced disability during long-term follow-up (adjusted hazard ratio, 0.33). There was a reduction in total knee arthroplasty in the LDRT group (hazard ratio, 0.51). The greatest benefit was seen for patients with baseline KL2 disease, with reductions in both disability and total knee arthroplasty (hazard ratios, 0.37 and 0.32, respectively).
"The combination of less disability and fewer knee replacements in these patients is particularly encouraging," co-author Bobby (Nagendra) Koneru, M.D., from Loyola University in Maywood, Illinois, said in a statement. "It suggests an opportunity to study whether treating inflammation earlier can change the longer course of the disease."
Several authors disclosed ties to the biotechnology, medical technology and medical device industries.
Clinical categories
Who's behind this story?
Gaby Clark
MA in English, copy editor since 2021 with experience in higher education and health content. Dedicated to trustworthy science news. Full profile →
Andrew Zinin
Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →
© 2026 HealthDay. All rights reserved.
Citation: ASTRO: Low-dose radiotherapy shows potential in early knee osteoarthritis (2026, October 8) retrieved 8 October 2026 from https://medicalxpress.com/news/2026-10-astro-dose-radiotherapy-potential-early.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
来源:Medical Xpress · medicalxpress.com